Literature DB >> 3102006

The role of the tumor board in a community hospital.

G E Gross.   

Abstract

A hospital tumor board is a multidisciplinary group of physicians that meets on a regular basis to review cancer cases. Through regular meetings, the tumor board will improve the quality of cancer care, provide educational opportunities for participants, and become an asset to the hospital and to the community. The use of multidisciplinary tumor-board consultations can ensure that the cancer patient has access to the best current thinking about cancer management. This structure provides the individual practitioner and his hospital with the educational, quality assurance, and legal mechanisms to deliver state-of-the-art care.

Entities:  

Mesh:

Year:  1987        PMID: 3102006     DOI: 10.3322/canjclin.37.2.88

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  13 in total

1.  Is there a role for clinical practice guidelines in multidisciplinary tumor board meetings? A descriptive study of knowledge transfer between research and practice.

Authors:  Xanthoula Kostaras; Melissa A Shea-Budgell; Emily Malcolm; Jacob C Easaw; Wilson Roa; Neil A Hagen
Journal:  J Cancer Educ       Date:  2012-03       Impact factor: 2.037

2.  Tumor boards: beyond the patient care conference.

Authors:  Abdul Rahman Jazieh
Journal:  J Cancer Educ       Date:  2011-09       Impact factor: 2.037

3.  Physician and Practice Characteristics Influencing Tumor Board Attendance: Results From the Provider Survey of the Los Angeles Women's Health Study.

Authors:  Kevin S Scher; Diana M Tisnado; Danielle E Rose; John Lloyd Adams; Clifford Y Ko; Jennifer L Malin; Patricia A Ganz; Katherine L Kahn
Journal:  J Oncol Pract       Date:  2011-03       Impact factor: 3.840

4.  Tumor board participation among physicians caring for patients with lung or colorectal cancer.

Authors:  Kenneth L Kehl; Mary Beth Landrum; Katherine L Kahn; Stacy W Gray; Aileen B Chen; Nancy L Keating
Journal:  J Oncol Pract       Date:  2015-04-28       Impact factor: 3.840

Review 5.  Treatment of limited disease small cell lung cancer: the multidisciplinary team.

Authors:  Markus Glatzer; Achim Rittmeyer; Joachim Müller; Isabelle Opitz; Alexandros Papachristofilou; Ioannis Psallidas; Martin Früh; Diana Born; Paul Martin Putora
Journal:  Eur Respir J       Date:  2017-08-24       Impact factor: 16.671

6.  Addressing clinical trials: can the multidisciplinary Tumor Board improve participation? A study from an academic women's cancer program.

Authors:  Lindsay Kuroki; Ashley Stuckey; Priya Hirway; Christina A Raker; Christina A Bandera; Paul A DiSilvestro; Cornelius O Granai; Robert D Legare; Bachir J Sakr; Don S Dizon
Journal:  Gynecol Oncol       Date:  2009-12-29       Impact factor: 5.482

7.  Cancer multidisciplinary team meetings: evidence, challenges, and the role of clinical decision support technology.

Authors:  Vivek Patkar; Dionisio Acosta; Tim Davidson; Alison Jones; John Fox; Mohammad Keshtgar
Journal:  Int J Breast Cancer       Date:  2011-07-17

8.  Molecular Tumor Boards: Ethical Issues in the New Era of Data Medicine.

Authors:  Henri-Corto Stoeklé; Marie-France Mamzer-Bruneel; Charles-Henry Frouart; Christophe Le Tourneau; Pierre Laurent-Puig; Guillaume Vogt; Christian Hervé
Journal:  Sci Eng Ethics       Date:  2017-03-09       Impact factor: 3.525

9.  Digital Tumor Board Solutions Have Significant Impact on Case Preparation.

Authors:  Richard D Hammer; Donna Fowler; Lincoln R Sheets; Athanasios Siadimas; Chaohui Guo; Matthew S Prime
Journal:  JCO Clin Cancer Inform       Date:  2020-08

10.  FHIRChain: Applying Blockchain to Securely and Scalably Share Clinical Data.

Authors:  Peng Zhang; Jules White; Douglas C Schmidt; Gunther Lenz; S Trent Rosenbloom
Journal:  Comput Struct Biotechnol J       Date:  2018-07-29       Impact factor: 7.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.